Conflicts of interest in data monitoring of industry versus publicly financed clinical trials

Statistics in Medicine

Volumn 23, Issue 10, 2004, Pages 1519-1521

  Lachin, John M ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Data Monitoring in Clinical Trials; Dualities of interest; FDA guidance

Indexed keywords

ARTICLE; AWARENESS; CLINICAL STUDY; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; HUMAN; INDUSTRY; MEDICAL ETHICS; MEDICAL SPECIALIST; POLICY; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; RISK ASSESSMENT; STATISTICAL ANALYSIS;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

CLINICAL TRIALS; CLINICAL TRIALS DATA MONITORING COMMITTEES; CONFLICT OF INTEREST; DATA INTERPRETATION, STATISTICAL; DRUG INDUSTRY; ETHICS, PROFESSIONAL; FINANCING, GOVERNMENT; GUIDELINES; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); STATISTICS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 2442708965     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1787     Document Type: Article

References (2)

1. Meinert CL. Clinical Trials: Design, Conduct and Analysis. Oxford University Press: New York, 1986.
2. National Institutes of Health, NIH Guide for Grants and Contracts 1979, 8(8):29.